I am a Radiochemist with a passion for radiochemistry and nuclear medicine. In recent years, my primary interests are radiolabeling and coordinating various radioisotopes including but not limited to radiometals such as Cu-64, Cu-67, Ga-68, Zr-89, and Lu-177, and radiohalogens such as I-125, I-131, and At-211.With a PhD in Chemistry, I have engaged in various facets of radiopharmaceutical development, encompassing the labeling and evaluation of radiolabeled compounds both in vitro and in vivo. My expertise spans across both diagnostic (PET) and therapeutic radionuclides. I have experience with HPLC, radiochemistry synthesis, purification and separation method (SPE), equipment (HPLC, TLC, LC-MS) . In my current role, I focus on evaluating radiohalogenated compounds, particularly At-211, for potential clinical applications.